Kings Path Partners’s AnaptysBio ANAB Stock Holding History

Kings Path Partners’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$188K	Buy	+3,750	New	+$212K	0.05%	122

Other funds holding ANAB

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Kings Path Partners's ANAB Position: Q3 2026 in Review

Kings Path Partners opened a new position in AnaptysBio (ANAB) in Q3 2026: 3,750 shares worth $188K. The stake represents 0.05% of the portfolio and ranks #122 among its holdings.

18 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

Kings Path Partners held 3,750 shares of AnaptysBio worth $188K as of Q3 2026.
AnaptysBio was a new Kings Path Partners position in Q3 2026.
AnaptysBio made up 0.05% of Kings Path Partners's portfolio in Q3 2026, its #122 holding.
18 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.